BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11056771)

  • 1. Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population.
    Fong YK; Ruban P; Yeo SJ; Lee BP; Lo NN; Seow KH; Ng SC
    Ann Acad Med Singap; 2000 Jul; 29(4):439-41. PubMed ID: 11056771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of deep-vein thrombosis after total knee arthroplasty in Asian patients. Comparison of low-molecular-weight heparin and indomethacin.
    Wang CJ; Wang JW; Weng LH; Hsu CC; Huang CC; Yu PC
    J Bone Joint Surg Am; 2004 Jan; 86(1):136-40. PubMed ID: 14711956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total knee replacement: prevention of deep-vein thrombosis using pharmacological (low-molecular-weight heparin) and mechanical (intermittent foot sole pump system) combined prophylaxis. Preliminary results.
    Giannoni MF; Ciatti R; Capoccia L; Ruggiero M; Dauri M; Mariani PP
    Int Angiol; 2006 Sep; 25(3):316-21. PubMed ID: 16878083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep vein thrombosis after total knee replacement.
    Ruban P; Yeo SJ; Seow KH; Tan SK; Ng SC
    Ann Acad Med Singap; 2000 Jul; 29(4):428-33. PubMed ID: 11056769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system.
    Blanchard J; Meuwly JY; Leyvraz PF; Miron MJ; Bounameaux H; Hoffmeyer P; Didier D; Schneider PA
    J Bone Joint Surg Br; 1999 Jul; 81(4):654-9. PubMed ID: 10463739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients.
    Ho YH; Seow-Choen F; Leong A; Eu KW; Nyam D; Teoh MK
    Dis Colon Rectum; 1999 Feb; 42(2):196-202; discussion 202-3. PubMed ID: 10211496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study.
    Nathan S; Aleem MA; Thiagarajan P; Das De S
    J Orthop Surg (Hong Kong); 2003 Dec; 11(2):184-9. PubMed ID: 14676345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative heparin in addition to postoperative low-molecular-weight heparin for thromboprophylaxis in total knee replacement.
    Mant MJ; Russell DB; Johnston DW; Donahue PA
    J Bone Joint Surg Br; 2000 Jan; 82(1):48-9. PubMed ID: 10697313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short versus extended thromboprophylaxis after total knee arthroplasty: a randomized comparison.
    Barrellier MT; Lebel B; Parienti JJ; Mismetti P; Dutheil JJ; Vielpeau C; ;
    Thromb Res; 2010 Oct; 126(4):e298-304. PubMed ID: 20797774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumatic compression device does not show effective thromboprophylaxis following total knee arthroplasty in a low incidence population.
    Kim KI; Kim DK; Song SJ; Hong SJ; Bae DK
    Orthop Traumatol Surg Res; 2019 Feb; 105(1):71-75. PubMed ID: 30555017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism following microsurgical breast reconstruction: an objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis.
    Lemaine V; McCarthy C; Kaplan K; Mehrara B; Pusic AL; Cordeiro PG; Disa JJ
    Plast Reconstr Surg; 2011 Apr; 127(4):1399-1406. PubMed ID: 21187811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.